查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1538166

永生化細胞株市場報告：2030 年趨勢、預測與競爭分析

Immortalized Cell Line Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

永生化細胞株的趨勢與預測

預計2024年至2030年全球永生化細胞株市場將以6.8%的複合年成長率成長。該市場的主要驅動力是需要器官移植的人數不斷增加、癌症患者數量不斷增加，以及該系列產品在藥物發現、診斷測試、再生醫學和生物技術研究等各種應用中的廣泛使用。全球永生化細胞株市場的未來看起來充滿希望，製藥/生物製藥、CRO 和實驗室市場充滿機會。

分段永生化細胞株

研究包括按產品類型、應用和地區對全球永生化細胞株的預測。

永生化細胞株市場洞察

Lucintel 預測幹細胞療法將在預測期內達到最高成長。

在該市場中，藥品和生物製藥在預測期內仍將是最大的細分市場。

由於癌症盛行率不斷上升，並且是生物技術和製藥行業的繁榮地區，北美在整個預測期內仍將是最大的地區。

常問問題

Q1.市場成長預測是多少：

A1. 2024年至2030年，全球永生化細胞株市場預計將以6.8%的複合年成長率成長。

Q2. 影響市場成長的關鍵促進因素是：

A2. 該市場的主要驅動力是需要器官移植的人數不斷增加、癌症患者數量不斷增加，以及該系列產品在藥物發現、診斷測試、再生醫學和生物技術研究等各種應用中的廣泛使用。 。

Q3.市場的主要細分市場是：

A3.永生化細胞株市場在製藥/生物製藥、CRO和實驗室市場的前景廣闊。

Q4.市場的主要企業是：

A4.主要永生化細胞株公司如下：

  • Thermo Fisher Scientific
  • ATCC
  • Valneva
  • Sartorius
  • Lonza Group
  • Merck
  • Selexis
  • WuXi App
  • European Collection of Authenticated Cell Cultures
  • Corning Incorporated

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預測幹細胞療法將在預測期內達到最高成長。

Q6.未來五年預計哪些地區的市場成長最大？

A6. 由於癌症盛行率上升以及生物技術和製藥行業強勁，北美在預測期內仍然是最大的地區。

Q7. 可以客製化報告嗎？

A7。

目錄

第1章執行摘要

第2章全球永生化細胞株市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球永生化細胞株市場趨勢（2018-2023）與預測（2024-2030）
  • 按產品類型分類的永生化細胞株的全球市場
    • 幹細胞療法
    • 細胞移植
    • 藥物運輸
    • 其他
  • 按應用分類的永生化細胞株的全球市場
    • 藥品/生物製藥
    • CRO
    • 研究所
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 按地區分類的全球永生細胞株市場
  • 北美永生化細胞株市場
  • 歐洲永生化細胞株市場
  • 亞太永生細胞株市場
  • 其他地區永生化細胞株市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
  • 全球永生化細胞株市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球永生化細胞株市場產能
    • 全球永生化細胞株市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Thermo Fisher Scientific
  • ATCC
  • Valneva
  • Sartorius
  • Lonza Group
  • Merck
  • Selexis
  • WuXi App
  • European Collection of Authenticated Cell Cultures
  • Corning Incorporated
簡介目錄

Immortalized Cell Line Trends and Forecast

The future of the global immortalized cell line market looks promising with opportunities in the pharmaceutical and biopharmaceutical, contract research organization, and research laboratory markets. The global immortalized cell line market is expected to grow with a CAGR of 6.8% from 2024 to 2030. The major drivers for this market are increasing number of individuals require organ transplantation, growing number of cancer patients, and expanding usage of this line in various application, such as drug discovery, diagnostic testing, regenerative medicine, and biotechnology research.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Immortalized Cell Line by Segment

The study includes a forecast for the global immortalized cell line by product type, application, and region.

Immortalized Cell Line Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Stem Cell Therapy
  • Cell Transplantation
  • Drug Transport
  • Others

Immortalized Cell Line Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical and Biopharmaceutical
  • Contract Research Organizations
  • Research Laboratories
  • Others

Immortalized Cell Line Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Immortalized Cell Line Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies immortalized cell line companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the immortalized cell line companies profiled in this report include-

  • Thermo Fisher Scientific
  • ATCC
  • Valneva
  • Sartorius
  • Lonza Group
  • Merck
  • Selexis
  • WuXi App
  • European Collection of Authenticated Cell Cultures
  • Corning Incorporated

Immortalized Cell Line Market Insights

Lucintel forecasts that stem cell therapy is expected to witness the highest growth over the forecast period.

Within this market, pharmaceutical and biopharmaceutical will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period due to rise in the prevalence of cancer as well as existence of a thriving biotechnology and pharmaceutical industry in the region.

Features of the Global Immortalized Cell Line Market

Market Size Estimates: Immortalized cell line market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Immortalized cell line market size by product type, application, and region in terms of value ($B).

Regional Analysis: Immortalized cell line market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the immortalized cell line market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the immortalized cell line market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for immortalized cell line market?

Answer: The global immortalized cell line market is expected to grow with a CAGR of 6.8% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the immortalized cell line market?

Answer: The major drivers for this market are increasing number of individuals require organ transplantation, growing number of cancer patients, and expanding usage of this line in various application, such as drug discovery, diagnostic testing, regenerative medicine, and biotechnology research.

Q3. What are the major segments for immortalized cell line market?

Answer: The future of the immortalized cell line market looks promising with opportunities in the pharmaceutical and biopharmaceutical, contract research organization, and research laboratory markets.

Q4. Who are the key immortalized cell line market companies?

Answer: Some of the key immortalized cell line companies are as follows:

  • Thermo Fisher Scientific
  • ATCC
  • Valneva
  • Sartorius
  • Lonza Group
  • Merck
  • Selexis
  • WuXi App
  • European Collection of Authenticated Cell Cultures
  • Corning Incorporated

Q5. Which immortalized cell line market segment will be the largest in future?

Answer: Lucintel forecasts that stem cell therapy is expected to witness the highest growth over the forecast period.

Q6. In immortalized cell line market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rise in the prevalence of cancer as well as existence of a thriving biotechnology and pharmaceutical industry in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the immortalized cell line market by product type (stem cell therapy, cell transplantation, drug transport, and others), application (pharmaceutical and biopharmaceutical, contract research organizations, research laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Immortalized Cell Line Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Immortalized Cell Line Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Immortalized Cell Line Market by Product Type
    • 3.3.1: Stem Cell Therapy
    • 3.3.2: Cell Transplantation
    • 3.3.3: Drug Transport
    • 3.3.4: Others
  • 3.4: Global Immortalized Cell Line Market by Application
    • 3.4.1: Pharmaceutical and Biopharmaceutical
    • 3.4.2: Contract Research Organizations
    • 3.4.3: Research Laboratories
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Immortalized Cell Line Market by Region
  • 4.2: North American Immortalized Cell Line Market
    • 4.2.1: North American Immortalized Cell Line Market by Product Type: Stem Cell Therapy, Cell Transplantation, Drug Transport, and Others
    • 4.2.2: North American Immortalized Cell Line Market by Application: Pharmaceutical and Biopharmaceutical, Contract Research Organizations, Research Laboratories, and Others
  • 4.3: European Immortalized Cell Line Market
    • 4.3.1: European Immortalized Cell Line Market by Product Type: Stem Cell Therapy, Cell Transplantation, Drug Transport, and Others
    • 4.3.2: European Immortalized Cell Line Market by Application: Pharmaceutical and Biopharmaceutical, Contract Research Organizations, Research Laboratories, and Others
  • 4.4: APAC Immortalized Cell Line Market
    • 4.4.1: APAC Immortalized Cell Line Market by Product Type: Stem Cell Therapy, Cell Transplantation, Drug Transport, and Others
    • 4.4.2: APAC Immortalized Cell Line Market by Application: Pharmaceutical and Biopharmaceutical, Contract Research Organizations, Research Laboratories, and Others
  • 4.5: ROW Immortalized Cell Line Market
    • 4.5.1: ROW Immortalized Cell Line Market by Product Type: Stem Cell Therapy, Cell Transplantation, Drug Transport, and Others
    • 4.5.2: ROW Immortalized Cell Line Market by Application: Pharmaceutical and Biopharmaceutical, Contract Research Organizations, Research Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Immortalized Cell Line Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Immortalized Cell Line Market by Application
    • 6.1.3: Growth Opportunities for the Global Immortalized Cell Line Market by Region
  • 6.2: Emerging Trends in the Global Immortalized Cell Line Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Immortalized Cell Line Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immortalized Cell Line Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: ATCC
  • 7.3: Valneva
  • 7.4: Sartorius
  • 7.5: Lonza Group
  • 7.6: Merck
  • 7.7: Selexis
  • 7.8: WuXi App
  • 7.9: European Collection of Authenticated Cell Cultures
  • 7.10: Corning Incorporated